JonGlassMD
Neurology • Philadelphia, PAProfessor, Neurology and Neurological Surgery, Thomas Jefferson University Division chief, Neuro-oncology, Department of Neurology
Dr. Glass is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
909 Walnut St
2nd Floor
Philadelphia, PA 19107Phone+1 215-955-7000Fax+1 215-503-9357
Summary
- Dr. Jon Glass is a neurologist in Philadelphia, PA and is affiliated with multiple hospitals in the area, including Thomas Jefferson University Hospitals, Abington Hospital, and Jefferson Washington Township Hospital. He received his medical degree from State University of New York Downstate Medical Center College of Medicine and has been in practice 31 years. He specializes in neurooncology and is experienced in neuro-oncology and cns lymphoma, tumor immunology.
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1990 - 1992
Boston University Medical CenterResidency, Neurology, 1987 - 1990
SUNY Downstate Health Sciences UniversityInternship, Internal Medicine, 1986 - 1987
State University of New York Downstate Medical Center College of MedicineClass of 1986
Brandeis UniversityBA, Biochemistry, 1978 - 1982
Certifications & Licensure
MA State Medical License 1988 - 2025
NJ State Medical License 1995 - 2025
NY State Medical License 1995 - 2025
PA State Medical License 1992 - 2024- American Board of Psychiatry and Neurology Neurology
- UCNSNeuro-oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013
Clinical Trials
- Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma Start of enrollment: 2011 Sep 01
- Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Start of enrollment: 2012 Nov 09
- Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain Metastases
- Join now to see all
Publications & Presentations
PubMed
- 29 citationsCharacterization and outcomes of optic nerve gliomas: a population-based analysisMark V. Mishra, David W. Andrews, Jon Glass, James J. Evans, Adam P. Dicker
Journal of Neuro-Oncology. 2012-01-12 - 92 citationsPhase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide fo...Jon Glass, Minhee Won, Christopher J. Schultz, Daniel J. Brat, Nancy L. Bartlett
Journal of Clinical Oncology. 2016-09-27 - 246 citationsIbrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma.Christian Grommes, Alessandro Pastore, Nicolaos Palaskas, Sarah S. Tang, Carl Campos
Cancer Discovery. 2017-01-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
